Novel Pharmacotherapy for Dual Dependence

• Status: Unknown status
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effects of Topiramate and Cognitive Behavioral Therapy for the treatment of alcohol and cocaine dependence.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bankole Johnson
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Topiramate

Criteria

Inclusion Criteria:

• Subjects will be men and women between the ages of 18 years and older.

• Must meet at least three of the seven DSM IV diagnostic criteria for alcohol and cocaine dependence.

• Express a desire for treatment.

• Literacy in English and ability to read, understand, and complete the ratings scales and questionnaires accurately, follow instructions, and make use of the behavioral treatments are required.

• Prospective subjects must report cocaine use of at least once per month and alcohol consumption of ≥21 drinks/week and ≥14 drinks/week for men and women respectively, during the past 30 days

• At least one positive urine drug screen for cocaine at screen or baseline prior to randomization.

Exclusion Criteria:

Please contact site for additional information